Intravenous pamidronate for refractory rheumatoid arthritis

BACKGROUND: Patients with rheumatoid arthritis may be resistant to conventional treatment with disease-modifying antirheumatic drugs (DMARDs). On the other hand, biologic therapy is costly and may be inconvenient for many patients. Pamidronate is a potent bisphosphonate with the capacity of modifyin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Salesi, Mansour, Mottaghi, Peyman, Karimifar, Mansour, Farajzadegan, Ziba
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2012
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634265/
https://ncbi.nlm.nih.gov/pubmed/23626604
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki